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nificant lower risk of rectal colonization for ertapenem resistant Escherichia
coli than those who received flomoxef or moxifloxacin. The rate of Pseudo-
monas colonization did not differ between the three study Pseudomonas-
sparing antibiotics, and the colonization rate among all study patients was
16.5%.
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CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE, AN EMERGING
PROBLEM IN A TERTIARY HEALTHCARE SETTING
C. S. J. Teh 1,*, Y. M. Low 1, C. W. Chong 2, M. Y. Md Yusof 1. 1Department of
Medical Microbiology, Faculty of Medicine, University of Malaya, 50603
Kuala Lumpur; 2Department of Life Sciences, International Medical
University, Bukit Jalil, Malaysia
Purpose: The emergence of Carbapenem-resistant Enterobacteriaceae
(CRE) has giving rise to public health attention as they have now spreaded
to every part of the world. Recently, Malaysia has been alarmed by the
occurrence of Klebsiella pneumoniae isolates carrying NDM-1 and KPC genes,
which also known as high-consequence antibiotic resistance threats. Here,
we described the in-vitro activity of broad-spectrum antibiotics and the
mechanism of resistant used by Carbapenemase-producing K. pneumoniae
strains of different genotype.
Methods: The strains used in the study were previously isolated from pa-
tients admitted to Universiti Malaya Medical Centre (UMMC). The strains
were genotyped using PFGE and Carbapenemase production was confirmed
via modified Hodge Test. Susceptibility of the strains to Aminoglycosides,
Carbapenems, Cephalosporins, Penicilin, Quinolone, Tetracycline, and Poly-
peptides were determined using Kirby Bauer method and the Minimum inhib-
itory concentrations of each antibiotic were confirmed using E-test. The
presences of carbapenemase hydrolyzing genes as well as the genes encod-
ing ESBL were determined.
Results: A total of 17 Carbapenem-resistant K. pneumoniae were subtyped
into 9 pulsotypes. The prevalence of OXA48 among the strains was high
(71%). The OXA48 eproducing strains were subtyped into 5 different pulso-
types where 8 strains shared similar pulsotype. There were 8 KPC-, 2 IMP-
and 1 NDM- positive strains detected. However, the presence of these carba-
penemase hydrolyzing genes was weakly correlated to the genotypes of the
strains. All the strains showed high resistance to the antibiotics tested
except for Tigecycline and Colistin.
Conclusions: The presence of highly diverse clinical isolates with multiple
genetic mechanisms for Carbapenemases production posed a significant
threat that requiring urgent and aggressive action in health care settings.
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MOBILIZATION OF NDM-ISCR1 ELEMENT IN ESCHERICHIA COLI IN A
PATIENT
Juan Li *, Jingxing Lu, Jie Che, Jianguo Xu. State Key Laboratory for
Infectious Disease Prevention and Control, National Institute for
Communicable Disease Control and Prevention, China CDC
Purpose The goal of this work was to report mobilization of NDM-ISCR1 in
two Escherichia coli strains isolated in a patient, and to trigger deep
pondering on NDM-1 horizontal transfer.
Methods Antibiotic susceptibility was tested by Vitek Compact 2 system and
E-test. The genotype was performed by Pulse Field Gel Electrophoresis
(PFGE). Resistance determinants were detected by PCR and sequencing.
Plasmids characters were analyzed by PFGE-S1, Southern hybridization and
sequencing.
Results The two E. coli strains E3 and E4 had similar susceptibility with resis-
tance to ciprofloxacin, cefotaxime aztreonam and sensitivity to amikacin,
colistin sulphate and tigecycline, except E3 resistant to piperacillin/tazo-
bactam, carbapenems while E4 sensitive to them. PFGE, PFGE-S1and south-
ern blot revealed that the two strains had identical PFGE patterns and
plasmid patterns. Although E3 and E4 both harboring a 58kb plasmid, only
the 58kb plasmid in E3 bearing blaNDM-1. Plasmids sequencing revealed
that the 58 kb plasmid was almost identical in the two strains, but E3 carried
an additional NDM-ISCR1element.Conclusions: Two E. coli strains which isolated from a patient were almost
identical, except one of them carrying an additional NDM-ISCR1 element
and resistant to carbapenems. The NDM-ISCR1 element was most likely to
have mediated the NDM-1 transfer between the two E. coli strains in a pa-
tient, providing a vehicle for NDM-1 mobilization.
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SCCMEC TYPING OF MRSA ISOLATES FROM A TERTIARY CARE HOSPITAL IN
INDIA
Madhuri Kulkarni 1,*, Manjula S.R 2, Vineeth Rajan 3, Abhishek Bhandiwad 4.
1Dept. of Microbiology, JSS medical college, Mysore; 2Dept. of Microbiology,
JSS medical college, Mysore; 3Dept. of Studies in Microbiology, University of
Mysore, Mysore; 4Abhaya Clinic, Mysore
Purpose: MRSA is the most common multidrug resistant pathogen in hospi-
tals world over. Clinical implications of community acquired infections are
of increasing concern. CA MRSA is usually associated with SCC mec types 4
and 5 in various studies. Staphylococcal cassette chromosome typing is an
epidemiological tool to distinguish CA MRSA from HA MRSA.
Methods: MRSA was phenotypically detected among clinical isolates of
Staphylococcus aureus at Department of Microbiology JSS hospital, Mysore
over the period of 1yr. 58 isolates with MIC > 4mg/ml were subjected to
multiplex PCR for mecA detection and SCCmec typing.
Results: Of the 58 isolates subjected to SCC mec typing, 45 belonged to type
IV, 5 to type V and 8 could not be typed. Among the type IV isolates probable
source of infection was community acquired as the hospital stay was less
than 2 days; clinical presentation were carbuncle, gluteal abscess, cervical
abscess, necrotizing fasciitis and pneumonia.
Conclusion: CA MRSA infections are more common as compared to HA MRSA
in our hospital and are associated with SCC mec types 4 and 5.
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LINEZOLID-RESISTANT MRSA STRAINS SEQUENTIALLY ISOLATED FROM AN
ELDERLY PATIENT WITH PNEUMONIA DURING PROLONGED THERAPY
WITH LINEZOLID
Shan Zhou, Xiuli Xu, Jiayun Liu, Yueyun Ma, Peihong Yang, Xiaoke Hao.
Department of Clinical Laboratory, Xijing Hospital, Fourth Military Medical
University, Xi’an 710032, China
Purpose: To describe the emergence of linezolid-resistant methicillin-resis-
tant Staphylococcus aureus (MRSA) strains with a 23S rRNA mutation
Figure 1 The characters of two E. coli strains. (a)Drug susceptibility. (b)
PFGE-XbaI patterns. (c)PFGE-S1 patterns. (d)Southern-blot with blaNDM
probe of (c). (e) Comparative sequence analyses.
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term linezolid treatment.
Methods: A retrospective analysis was conducted to calculate the cumula-
tive amount of linezolid administered to an elderly patient with pneumonia
during prolonged therapy with linezolid. Three sequential isolates were
identified, its minimum inhibitory concentration (MIC), homology and drug
resistant related genes (cfr, 23S rRNA) were investigated.
Results: One linezolid-resistant strain of methicillin-resistant Staphylo-
coccus aureus (MRSA) was isolated from sputum of the patient at Xijing Hos-
pital. The MIC of linezolid had increased from 1.5 mg/ml of initial strain 083
in March 2012 to subsequent 4.0 mg/ml of strain 158 in November 2012 and
16.0 mg/ml of strain 231 in March 2013 respectively. The increasing MIC
values to linezolid were directly correlated with the cumulative amount of
linezolid 118.8 g administered over 99 days. Strain 158 had heterogeneous
resistance to linezolid. Molecular typing showed that three MRSA strains
belonged to MLST ST-239 (spa t-030) with 98.8% homology. Cfr mutation
was not detected but 23S rRNA mutation G2603T was confirmed in strains
158 and 231.
Conclusions: This is the first case of linezolid-resistant MRSA isolated in
China. The long-term use of linezolid for the treatment of MRSA infection
was associated with a 23S rRNA G2603T mutation, which mediates heteroge-
neous resistance to linezolid. And the strain with heterogeneous resistance
might progress to a high-level linezolid-resistant strain when re-exposed to
linezolid.
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CORRELATION OF MOLECULAR TYPES WITH ANTIMICROBIAL
SUSCEPTIBILITY PROFILES AMONG 670 MECA-POSITIVE MRSA ISOLATES
FROM STERILE SITES (TIST STUDY, 2006-2010)
Wei-Yao Wang 1,2, Tzong-Shi Chiueh 3, Yuan-Ti Lee 4, Shin-Ming Tsao 4.
1Feng-Yuan Hospital, Taichung, Taiwan; 2Central Taiwan University of
Science and Technology, Taichung, Taiwan; 3Tri-Service General Hospital
and National Defense Medical Center, Taipei, Taiwan; 4Chung Shan Medical
University Hospital, Taichung, Taiwan
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is the
most frequent organism that causes severe healthcare- and community-
associated infections. Association of molecular types and antimicrobial
susceptibility test (AST) profiles has been reported. The goal is to corre-
late various molecular types with AST profiles of MRSA isolates from
Taiwan.
Materials and Methods: MRSA from sterile sites were collected during 5
years from 22 hospitals (Tigecycline In-vitro Surveillance in Taiwan e
TIST 2006e2010) and AST including seventeen antibiotic regimens and
inducible macrolide-lincosamide- streptogramin B (MLSBi) phenotype
were determined by Vitek-II automated system. Molecular types including
SCCmec, spa, and dru were determined by PCR and nucleotide
sequencing. Multidrug resistance (MDR) was defined an isolate with resis-
tance to more than or equal to three non-b-lactam antibiotics. Correlation
with molecular types with antibiotic resistance was determined by
Fisher’s exact test.
Results: Totally 670 mecA+ MRSA were collected, among which most were
from blood (627, 93.6%). The susceptibility rates determined by Vitek-II
were as followed: linezolid and teicoplanin (100%), vancomycin (99.9%),
tigecycline (99.7%), daptomycin (95.1%), fusidic acid (85.5%), rifampicin
(68.7%), trimethoprim (53.7%), moxifloxacin (36%), tetracycline (34.2%),
and less than 10% for cefoxitin, cefazolin, penicillin, oxacillin, erythro-
mycin, clindamycin, and ampicillin/sulbactam. MRSA with MDR (542,
80.9%) was associated with molecularly HA-MRSA (e.g., SCCmecII&III;
spa t002&t037; agr group II; dru4, 12, and 14). (p from < 0.001 to <
0.01). MLSBi (57, 8.5%) correlated with molecular types of SCCmecIII&V,
spa t3525, and agr group III (p < 0.01). The compound annual growth
rate of susceptibility from 2006 to 2010 ranged from -2% of fusidic acid
to 13% of clindamycin and 17% of erythromycin, respectively.
Conclusions: MRSA from Taiwan had varied AST profiles and some with
increasing susceptibility within 5 years. Strains with particular molecularphenotypes had corresponding AST profiles that were distinct from those
of endemic MRSA clones reported.
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DISTRIBUTION AND DRUG RESISTANCE OF PATHOGENS CULTURED FROM
63229 BLOOD SPECIMENS
Linhan Feng, Xiuli Xu, Xin Fan, Jiayun Liu. Department of Clinical
Laboratory, Xijing Hospital, Fourth Military Medical University, Xi’an
710032, China
Purpose: Dynamic Monitoring and Analysis in our hospital from 2007 to 2013
clinical testing of blood culture samples isolated pathogen distribution and
drug resistance changes, the rational use of antimicrobial drugs for clinical
laboratory evidence.
Methods: Using BACTEC automated blood culture system on 63,229 blood
specimens for testing; application of automatic identification of bacteria
bacterial identification analyzer identified to species; bacterial susceptibil-
ity testing by KB method, according to the American Society for Clinical Lab-
oratory Standards Institute requirements standards; pathogen distribution
and antimicrobial susceptibility test results apply WHONET5.6 software for
statistical analysis.
Results: From a clinical inspection of 63,229 blood specimens, the positive
culture 4914, the positive rate of 7.77%, were detected pathogens 2196,
which accounted for 46.08 Enterobacteriaceae (1012/2196), nonfermenters
13.93 (306/2196) ; Staphylococcus 13.70 (301/2196), Enterococcus 8.24
(181/2196); mainly Gram-negative bacteria Escherichia coli, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, The
detection rates were 25.50%, 11.47%, 7.14%, 5.91%. Gram-positive bacteria
to coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus,
grass green hammer main separation rates were 10.40%, 7.42%,
6.87,3.91%. Fungal 7.05 (155/2196), the separation rate of the first two of
Candida albicans and Candida tropicalis, the detection rates were 2.18%,
2.00%; brucellosis 1.01 (32/2196), pollution bacteria 4.01 (88/2196), produc-
ing ESBLs of Escherichia coli and Klebsiella pneumoniae separation rates
were 75.53%, 55.51%; methicillin-resistant Staphylococcus aureus (MRSA)
isolation rate was 62.6%, not seized the resistance to vancomycin, line-
zolid-resistant Staphylococcus aureus.
Conclusions: Bloodstream infection pathogen distribution as Escherichia
coli, Klebsiella pneumoniae, coagulase-negative staphylococci, Staphylo-
coccus aureus, Enterococcus, Acinetobacter baumannii, Pseudomonas aeru-
ginosa. Clinical blood culture specimens should be strictly in accordance
with the norms adopted send execution to avoid pollution and improve the
quality inspection.
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ROLE OF CEFEPIME THERAPY FOR CARBAPENEM-RESISTANT KLEBSIELLA
PNEUMONIAE BLOODSTREAM INFECTIONS
Ching-Lung Lo 1,3, Nan-Yao Lee 1,3, Jing-Jou Yan 2, Ching-Chi Lee 1,3, Chia-
Wen Li 1,3, Ming-Chi Li 1,3, Wen-Chien Ko 1,3,*. 1Department of Internal
Medicine National Cheng Kung University Hospital, Tainan, Taiwan;
2Pathology, National Cheng Kung University Hospital, Tainan, Taiwan;
3Center for Infection Control National Cheng Kung University Hospital,
Tainan, Taiwan
Background: Infections with carbapenem-resistant Klebsiella pneumoniae
(CRKP) are emerging causes of morbidity and mortality at institutions world-
wide. In addition, the efficacy of cefepime for such infections is
controversial.
Methods: A retrospective study of monomicrobial bloodstream infections
(BSIs) caused by Klebsiella pneumoniae resistant to one of ertapenem, imi-
penem or meropenem, at a medical center between 2008 and 2013, was con-
ducted. The 30-day crude mortality was the primary end point.
